Octapharma Canada

Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. Globally, Octapharma employs more than 11,000 people to support the treatment of patients in 120 countries, with therapies across three therapeutic areas: Immunotherapy, Hematology and Critical Care. Octapharma Canada exists to improve the quality of life of Canadians living with rare diseases. In partnership with Canada’s blood agencies and top research hospitals, we pursue smart, evidence backed studies that answer critical clinical questions about life threatening bleeds and immune disorders. Fueled by purpose, passion, and the strength of our team, we turn those insights into cost effective therapies that raise the bar and deliver meaningful change for Canadians every day.